Eleonora Ballanti

848 total citations
18 papers, 649 citations indexed

About

Eleonora Ballanti is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Eleonora Ballanti has authored 18 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 8 papers in Immunology and 4 papers in Hematology. Recurrent topics in Eleonora Ballanti's work include Systemic Lupus Erythematosus Research (7 papers), Complement system in diseases (6 papers) and Rheumatoid Arthritis Research and Therapies (6 papers). Eleonora Ballanti is often cited by papers focused on Systemic Lupus Erythematosus Research (7 papers), Complement system in diseases (6 papers) and Rheumatoid Arthritis Research and Therapies (6 papers). Eleonora Ballanti collaborates with scholars based in Italy and Israel. Eleonora Ballanti's co-authors include Roberto Perricone, Maria Sole Chimenti, Carlo Perricone, G Di Muzio, Paola Triggianese, Paola Conigliaro, E. Greco, B. Kroegler, Paola Cipriani and Marta Ballanti and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Clinical & Experimental Immunology.

In The Last Decade

Eleonora Ballanti

17 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eleonora Ballanti Italy 12 357 266 121 90 77 18 649
Hitoshi Ogasawara Japan 19 368 1.0× 342 1.3× 68 0.6× 229 2.5× 116 1.5× 55 933
Juan Jakez-Ocampo Mexico 12 418 1.2× 368 1.4× 52 0.4× 68 0.8× 56 0.7× 18 703
Rebecca Subang Canada 15 252 0.7× 350 1.3× 122 1.0× 98 1.1× 30 0.4× 27 568
Mitsuhiro Iwahashi Japan 12 449 1.3× 366 1.4× 238 2.0× 153 1.7× 57 0.7× 18 914
Christianna Choulaki Greece 9 371 1.0× 196 0.7× 73 0.6× 190 2.1× 48 0.6× 13 575
Rufei Lu United States 16 447 1.3× 528 2.0× 76 0.6× 97 1.1× 67 0.9× 24 874
Tetsushi Aita Japan 9 480 1.3× 307 1.2× 135 1.1× 168 1.9× 50 0.6× 15 844
J. Simón Mexico 14 248 0.7× 412 1.5× 116 1.0× 36 0.4× 51 0.7× 23 667
Maida Wong United States 8 408 1.1× 243 0.9× 58 0.5× 112 1.2× 86 1.1× 12 741
Helena Enocsson Sweden 14 258 0.7× 208 0.8× 38 0.3× 90 1.0× 84 1.1× 26 502

Countries citing papers authored by Eleonora Ballanti

Since Specialization
Citations

This map shows the geographic impact of Eleonora Ballanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora Ballanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora Ballanti more than expected).

Fields of papers citing papers by Eleonora Ballanti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleonora Ballanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora Ballanti. The network helps show where Eleonora Ballanti may publish in the future.

Co-authorship network of co-authors of Eleonora Ballanti

This figure shows the co-authorship network connecting the top 25 collaborators of Eleonora Ballanti. A scholar is included among the top collaborators of Eleonora Ballanti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleonora Ballanti. Eleonora Ballanti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Conigliaro, Paola, Paola Triggianese, Eleonora Ballanti, et al.. (2019). Complement, infection, and autoimmunity. Current Opinion in Rheumatology. 31(5). 532–541. 84 indexed citations
2.
3.
Conigliaro, Paola, Maria Sole Chimenti, Paola Triggianese, et al.. (2016). Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor. Journal of International Medical Research. 44(1_suppl). 90–94. 9 indexed citations
4.
Triggianese, Paola, Maria Sole Chimenti, Elias Toubi, et al.. (2015). The autoimmune side of hereditary angioedema: insights on the pathogenesis. Autoimmunity Reviews. 14(8). 665–669. 21 indexed citations
5.
Triggianese, Paola, Maria Domenica Guarino, Eleonora Ballanti, Maria Sole Chimenti, & Roberto Perricone. (2014). Hereditary angioedema and autoimmunity.. PubMed. 16(10). 622–4. 9 indexed citations
6.
Chimenti, Maria Sole, Eleonora Ballanti, Paola Triggianese, & Roberto Perricone. (2014). Vasculitides and the Complement System: a Comprehensive Review. Clinical Reviews in Allergy & Immunology. 49(3). 333–346. 53 indexed citations
7.
Ballanti, Eleonora, Paola Conigliaro, Maria Sole Chimenti, et al.. (2014). Use of Anti‐Tumor Necrosis Factor Alpha Therapy in Patients with Concurrent Rheumatoid Arthritis and Hepatitis B or Hepatitis C: A Retrospective Analysis of 32 Patients. Drug Development Research. 75(S1). S42–5. 26 indexed citations
8.
Conigliaro, Paola, Paola Triggianese, Carlo Perricone, et al.. (2014). Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment. Clinical & Experimental Immunology. 177(1). 234–243. 46 indexed citations
10.
Migliore, Alberto, et al.. (2013). Biologic agents for rheumatoid arthritis: Can we hypothesize new strategies of treatment?. Medical Hypotheses. 82(1). 117–121. 2 indexed citations
11.
Ballanti, Eleonora, Carlo Perricone, E. Greco, et al.. (2013). Complement and autoimmunity. Immunologic Research. 56(2-3). 477–491. 121 indexed citations
12.
Giovannangeli, F, et al.. (2013). Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients. SHILAP Revista de lepidopterología. 2013. 1–5. 19 indexed citations
13.
Chimenti, Maria Sole, Carlo Perricone, Dario Graceffa, et al.. (2012). Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment.. PubMed. 30(1). 23–30. 45 indexed citations
14.
Chimenti, Maria Sole, Eleonora Ballanti, Carlo Perricone, et al.. (2012). Immunomodulation in psoriatic arthritis: Focus on cellular and molecular pathways. Autoimmunity Reviews. 12(5). 599–606. 75 indexed citations
15.
Ballanti, Eleonora, G Di Muzio, Lucia Novelli, Carlo Perricone, & Roberto Perricone. (2012). Churg-Strauss syndrome with neurologic manifestations: successful treatment with intravenous immunoglobulins.. PubMed. 14(9). 583–5. 4 indexed citations
16.
Perricone, Carlo, Caterina De Carolis, Roberto Giacomelli, et al.. (2011). Inhibition of the Complement System by Glutathione: Molecular Mechanisms and Potential Therapeutic Implications. International Journal of Immunopathology and Pharmacology. 24(1). 63–68. 11 indexed citations
17.
Ballanti, Eleonora, Carlo Perricone, G Di Muzio, et al.. (2011). Role of the complement system in rheumatoid arthritis and psoriatic arthritis: Relationship with anti-TNF inhibitors. Autoimmunity Reviews. 10(10). 617–623. 73 indexed citations
18.
Muzio, G Di, Carlo Perricone, Eleonora Ballanti, et al.. (2011). Complement System and Rheumatoid Arthritis: Relationships with Autoantibodies, Serological, Clinical Features, and Anti-TNF Treatment. International Journal of Immunopathology and Pharmacology. 24(2). 357–366. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026